Journal
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL
Volume 9, Issue 8, Pages 910-918Publisher
JOHN WILEY & SONS LTD
DOI: 10.1002/ueg2.12146
Keywords
complications; eosinophilic oesophagitis; oesophagus; proton pump inhibitors; treatment
Categories
Ask authors/readers for more resources
This study assessed the effectiveness of PPIs in treating EoE and evaluated whether patients were treated according to guidelines. Results showed that high-dose PPI treatment was effective in half of EoE patients, but conflicting symptomatic and histological responses were common. Complications were rare when PPIs were started, and one-third of patients were not rebiopsied as recommended.
Background Proton pump inhibitors (PPIs) are often the first drug of choice in the treatment of eosinophilic oesophagitis (EoE), and in Denmark 8 weeks of high-dose PPI therapy is recommended as first-line treatment followed by rebiopsying, reflecting international recommendations. Aims To assess the population-based effectiveness of PPIs in the treatment of EoE and evaluate whether patients were treated and followed according to the regional guideline. Methods This is a retrospective, registry-based, DanEoE cohort study of 236 adult EoE patients diagnosed between 2007 and 2017 in the North Denmark Region. After patient file revision, the EoE diagnosis was defined according to the AGREE 2 consensus. Symptomatic PPI response was defined as complete symptom resolution and histological remission (<15 eosinophils per high-power field). Results PPI treatment was initiated in 92% of the EoE patients. High- and low-dose PPIs were prescribed in 55% and 45% of the cases, respectively. When treated with high-dose PPIs, 68% of the patients were completely symptom-free, and 49% were in histological remission. In 39% of high-dose PPI-treated patients, the symptomatic and histological responses were conflicting. While treated with PPIs, complications were rare, with High-dose PPI treatment was effective in half of the EoE patients started on PPIs, but conflicting symptomatic and histological PPI responses were common. Complications were rare when PPIs were started. One-third of the patients were not rebiopsied as recommended.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available